MedTrace Logo

Everolimus Stent in Myocardial Infarction

NCT01684982 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2013-04-04

No results posted yet for this study

Summary

Randomized trial to test the efficacy and safety of newer Drug Eluting Stent generation in patient with acute myocardial infarction treated with primary percutaneous coronary intervention (PCI)

Conditions

  • Acute Myocardial Infarction

Interventions

DEVICE

everolimus eluting stent

experimental arm of a comparison between drug eluting stents

DEVICE

sirolimus eluting stent

control arm of a comparison between drug eluting stents

Sponsors & Collaborators

  • San Giuseppe Moscati Hospital

    lead OTHER

Principal Investigators

  • EMILIO DI LORENZO, MD PHD · AO MOSCATI AVELLINO ITALY

  • ROSARIO SAURO, MD · AO MOSCATI AVELLINO ITALY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684982 on ClinicalTrials.gov